Clin Med - Chronic Kidney Disease

Which of the following is not a major risk factor for chronic kidney disease?

What is the primary goal for glycemic control in patients with chronic kidney disease?

Which of the following is the preferred agent for hypertension control in patients with chronic kidney disease?

What is the main reason patients with stage 4 CKD are at increased risk of anemia?

How does protein restriction affect the progression of chronic kidney disease?

What is the screening guideline for CKD according to the USPSTF

Which of the following is not a component of the KDIGO classification system for chronic kidney disease?

At what stage of chronic kidney disease (CKD) do patients generally present with manifestations of cardiovascular disease, anemia, and abnormal bone and mineral metabolism?

What is the estimated glomerular filtration rate (eGFR) range for Stage 3 chronic kidney disease?

Which of the following is a recommended lifestyle change for patients with chronic kidney disease?

What is the primary reason for the increased risk of metabolic bone disease in patients with chronic kidney disease?

Which of the following statements regarding the diagnosis of chronic kidney disease is true?

Which of the following statements regarding the risk of cardiovascular disease in patients with chronic kidney disease is true?

According to the KDIGO guidelines, at what age should a statin medication be considered for patients with chronic kidney disease?

Which of the following statements regarding the staging of chronic kidney disease is true?

Which of the following statements regarding the treatment of hypertension in patients with chronic kidney disease is true?

What is the range of eGFR for Stage 2 chronic kidney disease?

According to the KDIGO guidelines, at what age should a statin medication be considered for patients with chronic kidney disease?

How does protein restriction affect the progression of chronic kidney disease?

Which type of dialysis is preferred for children with end-stage renal disease?

What is the primary benefit of a living donor kidney transplant compared to a deceased donor transplant?

When is acute transplant rejection most common after a kidney transplant?

Which of the following is true regarding a living kidney donor?

What is the main reason patients on dialysis are at increased risk of opportunistic infections?

Which of the following is the primary reason kidney transplant is the preferred treatment for end-stage renal disease?

Which of the following is true about acute transplant rejection?

What is the primary purpose of using a non-tunnel catheter for in-patient care?

What is the eGFR threshold at which a patient will need dialysis for End Stage Kidney Disease?

When can a patient enter the transplant wait list according to the text?

Which arm access option for hemodialysis has the highest thrombosis and infection rates?

How long does it take for an AV graft to mature for use in a patient?

What is the function of adding dextrose to the dialysate in hemodialysis?

Which hemodialysis access option is temporary and used for emergency and urgent situations?

What is the difference between peritoneal dialysis and kidney transplant in terms of location?

Which type of donor kidney donation typically results in better outcomes and lower rejection rates?

When is acute transplant rejection most commonly seen after a kidney transplant?

What condition makes a living donor ineligible to donate a kidney?

Why are patients with End-Stage Kidney Disease (ESKD) on dialysis more at risk for opportunistic infections compared to transplant patients?

What is the preferred hemodialysis access method according to the text?

How long does it typically take for an arteriovenous (AV) fistula to become accessible for hemodialysis?

Which of the following statements about arteriovenous (AV) grafts is true?

What is one advantage of a tunnel dialysis catheter compared to other hemodialysis access methods?